TTN and sarcopenia: In conclusion, our results suggest that serum TTN, N-TTN and miR-451a could be valid biomarkers for sarcopenia and support the hypothesis that modulation of non-coding RNAs is a pivotal epigenetic mechanism involved in recovery after rehabilitative treatment of sarcopenic patients.